CHRISTINE BEAUJEAN: Open Payments
NPI 1548816622 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,297 in 131 payments from 17 companies in 2025. Trend: 2023 $2,448 · 2024 $2,631 · 2025 $2,297
Food & beverage: $2,297
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $421 |
| UCB, Inc. | 10 | $330 |
| ABBVIE INC. | 37 | $277 |
| GENZYME CORPORATION | 7 | $237 |
| Novartis Pharmaceuticals Corporation | 10 | $209 |
| E.R. Squibb & Sons, L.L.C. | 12 | $151 |
| Lilly USA, LLC | 7 | $145 |
| LEO Pharma Inc. | 6 | $128 |
| Incyte Corporation | 5 | $107 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $75 |
Products named: TREMFYA, Bimzelx, DUPIXENT, SKYRIZI, Sotyktu, TALTZ, COSENTYX, OPZELURA.
Industry payments across OH — which companies pay providers there.
